US Patent Issued to ZHEJIANG TERUISI PHARMACEUTICAL on June 10 for "CD20-targeted antibody coupling pharmaceutical preparation" (Chinese Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,324,840, issued on June 10, was assigned to ZHEJIANG TERUISI PHARMACEUTICAL INC. (Zhejiang, China).

"CD20-targeted antibody coupling pharmaceutical preparation" was invented by Youling Wu (Huzhou, China), Yujie Zhang (Huzhou, China) and Jiali Lu (Huzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A CD20-targeted antibody coupling pharmaceutical preparation, specifically a preparation comprising a CD20-targeted antibody coupling medication represented by formula I and an excipient. The antibody coupling pharmaceutical preparation has prominent antitumor effect."

The patent was filed on Feb. 14, 2018, under Application No. 16/486,862.

*For fur...